Patrick A. Mayes, EVP & Chief Scientific Officer at INCYTE CORP (INCY), sold 11,361 shares at $95.58 ($1.1M) on 2025-12-10, disclosed to the SEC on 2025-12-12.
Scheduled sale ($1.1M) by EVP & Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $95.58 | 5,553 | $531K | 48.9% |
| 2 | $95.58 | 5,553 | $531K | 48.9% |
| 3 | $94.94 | 255 | $24K | 2.2% |
| Total | $95.57 avg | 11,361 | $1.1M | 100% |
| Filing → |